Michel Tauc

8PUBLICATIONS
11CO-AUTHORS
Biologically active moleculesEcological impacts of climate change and ecological adaptationMolecular targetsHaematological tumoursElectrochemical energy storage and conversion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 10, 2026
Novel triazole-adenosine conjugates as mammalian seryl-tRNA synthetase inhibitors to protect cells from ischemia-reperfusion injury.

|Feb 11, 2023
Renal Ischemia Tolerance Mediated by eIF5A Hypusination Inhibition Is Regulated by a Specific Modulation of the Endoplasmic Reticulum Stress.

Nicolas Melis, Isabelle Rubera, Sebastien Giraud

|Jan 11, 2022
Akt Inhibition as Preconditioning Treatment to Protect Kidney Cells against Anoxia.

Nicolas Melis, Romain Carcy, Isabelle Rubera

|Dec 25, 2021
The eukaryotic initiation factor 5A (eIF5A1), the molecule, mechanisms and recent insights into the pathophysiological roles.

Michel Tauc, Marc Cougnon, Romain Carcy

|Mar 18, 2021
Inhibition of eIF5A hypusination reprogrammes metabolism and glucose handling in mouse kidney.

Marc Cougnon, Romain Carcy, Nicolas Melis

|Jul 04, 2020
Inhibition of eIF5A hypusination pathway as a new pharmacological target for stroke therapy.

Miled Bourourou, Elsa Gouix, Nicolas Melis

Pageof 2

Frequent Collaborators

5 joint publications

Didier F Pisani

2 joint publications

Christophe Duranton

2 joint publications

Isabelle Rubera

2 joint publications

Luc Pellerin